Aptuit LLC has expanded its existing 1600L scale API capability and commercial GMP API license, investing in scale and capabilities in formulation development, analytics and clinical manufacturing to serve Phase III and beyond, as well as a commercial GMP license for drug product.   Aptuit has added lab scale nanomilling; hot melt extrusion, and spray drying equipment including SEDDS/SMEDDS technology. The Phase II GMP production scale will increase to Phase III and commercial levels, with add...